Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Promis Neurosciences (PMN) had Return on Investments of 848.10% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.67M |
|
-- |
|
-- |
|
$10.77M |
|
$-10.77M |
|
$0.10M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.67M |
|
$-10.77M |
|
$-10.77M |
|
1.76M |
|
1.76M |
|
$-4.11 |
|
$-4.11 |
|
| Balance Sheet Financials | |
$9.18M |
|
-- |
|
-- |
|
$9.18M |
|
$10.41M |
|
-- |
|
$0.03M |
|
$10.44M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
2.15M |
|
| Cash Flow Statement Financials | |
$-28.12M |
|
$-0.00M |
|
$20.94M |
|
$13.29M |
|
$6.12M |
|
$-7.17M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
848.10% |
|
848.10% |
|
-116.24% |
|
|
Return on Investments |
848.10% |
$-0.58 |
|
$-16.00 |
|
$-16.00 |
|